Lymphatic endothelial cells as inducers of systemic peripheral tolerance
Lymphatic endothelial cells as inducers of systemic peripheral tolerance
批准号:
8775196
负责人:
VICTOR H ENGELHARD
金额:
$19.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-01 至 2016-11-30
关键词:
AntigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityCD8B1 geneCellsDendritic CellsDevelopmentEpitopesGene ExpressionGenetic TranscriptionGoalsHealthHumanLeadLymphaticLymphatic Endothelial CellsLymphatic vesselLymphoid TissueMalignant NeoplasmsMediatingMediator of activation proteinMessenger RNAModelingMolecularMonophenol MonooxygenasePeripheralPhenotypePlayPopulationProcessPropertyProteinsRegulatory ElementReticular CellRoleSelf ToleranceSinusStagingStromal CellsStructure of retinal pigment epitheliumT-LymphocyteThymic epithelial cellThymus GlandTissuesWorkbasecentral tolerancelymph nodesmelanocyteperipheral tolerancepreventresponsetraffickingtranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this application is to identify the molecular and cellular mechanisms that control the ability of lymph node resident lymphatic endothelial cells to induce peripheral immunological tolerance. We and two other groups have described a mechanism in which stromal cells in lymph nodes directly express proteins that are normally associated with other tissues. Direct presentation of epitopes derived from these proteins to CD8 T cells leads to abortive proliferation and deletion. Populations of lymph node stromal cells that have been shown to mediate this process include: extra thymic Aire-expressing cells (eTAC), fibroblastic reticular cells, and lymphatic endothelial cells. In particular, we have shown
that CD8 T cell tolerance to an epitope derived from tyrosinase, a protein whose expression is normally confined to melanocytes and retinal pigment epithelial cells, is mediated by lymph node resident lymphatic endothelial cells that adventitiously express it. The 3 lymph node stromal populations defined above express at least partially distinct subsets of peripheral tissue antigens. Peripheral tissue antigens are also expressed in the thymus under the influence of the autoimmune regulatory element Aire. Aire also controls the expression of peripheral tissue antigens in the eTAC lymph node stromal subset. However, neither fibroblastic reticular cells nor lymphatic endothelial cells express Aire, and the mechanisms that control transcription of peripheral tissue antigen mRNAs in these lymph node stromal populations are unknown. One goal of this application is to identify transcription factors that lead to peripheral tissue antige expression in lymphatic endothelial cells. This will illuminate new mechanisms for control of peripheral tissue antigen expression, apart from Aire, that underlie the development of systemic peripheral tolerance. Our preliminary work has established that the lymph node resident lymphatic endothelial cells differ from their counterparts that form tissue lymphatic vessels by elevated expression of peripheral tissue antigens and the ability to present tyrosinase epitopes to tyrosinase-specific T cells. Lymph node resident lymphatic endothelial cells also express a number of immunologically relevant molecules that are not expressed by their tissue lymphatic counterparts. Of these, the most important is PD-L1, which we have shown to be responsible for T cell deletion during tolerance induction. We have also established the existence of subpopulations of lymphatic endothelial cells in the lymph node itself, and shown that tolerance to tyrosinase is primarily induced by those that form the medullary sinus. Thus, the ability of lymphatic endothelial cells to induce peripheral tolerance is regulated by the LN microenvironment. A second major goal of this application is to identify the cellular and molecular aspects of the LN microenvironment that regulate this tolerogenic phenotype. This work will set the stage for further understanding of the role lymphatic endothelial cells may play in self-tolerance and the development of autoimmune disease in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
-
批准号:10194416
-
项目类别:
-
资助金额:$65.53万
-
财政年份:2019
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
-
批准号:10401362
-
项目类别:
-
资助金额:$50.72万
-
财政年份:2019
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
-
批准号:9926230
-
项目类别:
-
资助金额:$47.96万
-
财政年份:2019
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
-
批准号:10524125
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2019
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
-
批准号:10625302
-
项目类别:
-
资助金额:$50.72万
-
财政年份:2019
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
-
批准号:10759011
-
项目类别:
-
资助金额:$3.14万
-
财政年份:2019
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Lymph node-like vasculature and naive T cell infiltration into tumors
-
批准号:8813956
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2015
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Fluorescence molecular tomography to study T cell infiltration into tumors
-
批准号:8902076
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2014
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
-
批准号:8800677
-
项目类别:
-
资助金额:$43.01万
-
财政年份:2014
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
-
批准号:8930114
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2014
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Lymphatic endothelial cells as inducers of systemic peripheral tolerance
-
批准号:8622327
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2013
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Lymphatic endothelial cells as inducers of systemic peripheral tolerance
-
批准号:8658561
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2013
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
-
批准号:7317177
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2007
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
-
批准号:7640786
-
项目类别:
-
资助金额:$57.53万
-
财政年份:2007
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
-
批准号:7455335
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2007
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
-
批准号:7885483
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2007
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
-
批准号:8092754
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2007
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Immunology
-
批准号:7304770
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2006
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Vitiligo in Tyrosinase-specific TCR Transgenic Mice
-
批准号:6864875
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2004
-
负责人:VICTOR H ENGELHARD
-
依托单位:
Vitiligo in Tyrosinase-specific TCR Transgenic Mice
-
批准号:6782234
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2004
-
负责人:VICTOR H ENGELHARD
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: